May 23, 2018 5:51 PM ET

Healthcare Equipment and Supplies

Company Overview of Surmodics, Inc.

Executive Profile

Gary R. Maharaj

CEO, President & Director, Surmodics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 organization across 4 different industries.

See Board Relationships
54$1,722,568

Background

Mr. Gary R. Maharaj has been the Chief Executive Officer and President at SurModics, Inc. since December 27, 2010. Mr. Maharaj served as the Chief Executive Officer and President at Arizant Inc. He served as the Vice President of Philip Adam and Associates, a product development management consulting firm and in various management and research positions for the orthopedic and rehabilitation divisions of Smith & Nephew, PLC. He has been Director of Creagh Medical Ltd. ...

Corporate Headquarters

9924 West 74th Street
Eden Prairie, Minnesota 55344

United States

Phone: 952-500-7000
Fax: 952-500-7001

Board Members Memberships

2010-Present
CEO, President & Director
2014-Present
Director
2015-Present
Director

Education

Master's Degree
The University of Texas Southwestern Medical Center
MS
University Of Texas At Arlington
MBA
Carlson School of Business University of Minnesota
BS
The University of The West Indies, St. Augustine

Other Affiliations

Annual Compensation

Salary$481,000
Salary$525,675
Total Annual Compensation$1,006,675

Stocks Options

Restricted Stock Awards$375,000
Restricted Stock Awards$510,000
All Other Compensation$4,363
All Other Compensation$4,879
Exercised Options$130,587
Exercised Options Value$2,297,651
Exercisable Options$57,270
Exercisable Options$99,857
Exercisable Options Value$989,112
Exercisable Options Value$509,600
Unexercisable Options$113,079
Unexercisable Options$115,271
Unexercisable Options Value$1,036,172
Unexercisable Options Value$1,044,974
Total Value of Options$3,852,225
Total Value of Options$2,025,284
Total Number of Options$215,128
Total Number of Options$300,936

Total Compensation

Total Annual Cash Compensation$918,779
Total Annual Cash Compensation$872,568
Total Short Term Compensation$481,000
Other Long Term Compensation$379,879
Total Calculated Compensation$1,668,779
Total Calculated Compensation$1,722,568
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer Co-Founder, President, CEO & Executive Director
Regeneron Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Surmodics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.